# VASOPRESSIN IN DEXTROSE 5%
> **ANDA216963** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2024-02-09
## Drug
- **FDA Application Number:** ANDA216963
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VASOPRESSIN IN DEXTROSE 5%
- **Generic name:** VASOPRESSIN
- **Active ingredients:** VASOPRESSIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2024-02-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216963)
---
*AI Analytics · CC0 1.0*